vs
Side-by-side financial comparison of Huron Consulting Group Inc. (HURN) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $442.0M, roughly 1.4× Huron Consulting Group Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 6.9%, a 27.5% gap on every dollar of revenue. On growth, Huron Consulting Group Inc. posted the faster year-over-year revenue change (10.7% vs 4.8%). Over the past eight quarters, Huron Consulting Group Inc.'s revenue compounded faster (10.3% CAGR vs 4.6%).
Huron Consulting Group, commonly known as Huron, is a management consulting firm offering services to the healthcare, life sciences, commercial, and higher education industries.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
HURN vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $442.0M | $622.0M |
| Net Profit | $30.7M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | 11.4% | 62.4% |
| Net Margin | 6.9% | 34.4% |
| Revenue YoY | 10.7% | 4.8% |
| Net Profit YoY | -9.8% | 2.9% |
| EPS (diluted) | $1.71 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $442.0M | $622.0M | ||
| Q3 25 | $441.3M | $609.3M | ||
| Q2 25 | $411.8M | $578.7M | ||
| Q1 25 | $404.1M | $568.2M | ||
| Q4 24 | $399.3M | $593.6M | ||
| Q3 24 | $378.1M | $564.7M | ||
| Q2 24 | $381.0M | $537.3M | ||
| Q1 24 | $363.4M | $568.0M |
| Q4 25 | $30.7M | $214.2M | ||
| Q3 25 | $30.4M | $288.2M | ||
| Q2 25 | $19.4M | $30.2M | ||
| Q1 25 | $24.5M | $238.3M | ||
| Q4 24 | $34.0M | $208.2M | ||
| Q3 24 | $27.1M | $544.0M | ||
| Q2 24 | $37.5M | $102.0M | ||
| Q1 24 | $18.0M | $4.8M |
| Q4 25 | 11.4% | 62.4% | ||
| Q3 25 | 11.3% | 70.1% | ||
| Q2 25 | 11.1% | 36.3% | ||
| Q1 25 | 8.1% | 94.0% | ||
| Q4 24 | 11.8% | 60.9% | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 15.6% | 50.2% | ||
| Q1 24 | 5.5% | -13.0% |
| Q4 25 | 6.9% | 34.4% | ||
| Q3 25 | 6.9% | 47.3% | ||
| Q2 25 | 4.7% | 5.2% | ||
| Q1 25 | 6.1% | 41.9% | ||
| Q4 24 | 8.5% | 35.1% | ||
| Q3 24 | 7.2% | 96.3% | ||
| Q2 24 | 9.8% | 19.0% | ||
| Q1 24 | 5.0% | 0.8% |
| Q4 25 | $1.71 | $0.49 | ||
| Q3 25 | $1.71 | $0.67 | ||
| Q2 25 | $1.09 | $0.07 | ||
| Q1 25 | $1.33 | $0.55 | ||
| Q4 24 | $1.82 | $0.46 | ||
| Q3 24 | $1.47 | $1.21 | ||
| Q2 24 | $2.03 | $0.23 | ||
| Q1 24 | $0.95 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.5M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $528.6M | $9.7B |
| Total Assets | $1.5B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.5M | $618.7M | ||
| Q3 25 | $23.9M | $938.9M | ||
| Q2 25 | $61.0M | $631.9M | ||
| Q1 25 | $23.4M | $1.1B | ||
| Q4 24 | $21.9M | $929.0M | ||
| Q3 24 | $18.5M | $950.1M | ||
| Q2 24 | $17.6M | $1.8B | ||
| Q1 24 | $18.6M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $528.6M | $9.7B | ||
| Q3 25 | $499.8M | $9.6B | ||
| Q2 25 | $475.0M | $9.5B | ||
| Q1 25 | $494.3M | $9.8B | ||
| Q4 24 | $561.3M | $10.3B | ||
| Q3 24 | $522.8M | $10.3B | ||
| Q2 24 | $500.6M | $9.8B | ||
| Q1 24 | $495.6M | $9.9B |
| Q4 25 | $1.5B | $19.6B | ||
| Q3 25 | $1.5B | $19.3B | ||
| Q2 25 | $1.5B | $18.3B | ||
| Q1 25 | $1.4B | $17.6B | ||
| Q4 24 | $1.3B | $18.2B | ||
| Q3 24 | $1.3B | $18.0B | ||
| Q2 24 | $1.3B | $17.7B | ||
| Q1 24 | $1.3B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.4M | $827.1M |
| Free Cash FlowOCF − Capex | $123.8M | — |
| FCF MarginFCF / Revenue | 28.0% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | 4.12× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $183.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.4M | $827.1M | ||
| Q3 25 | $93.8M | $702.6M | ||
| Q2 25 | $80.0M | $364.0M | ||
| Q1 25 | $-106.8M | $596.1M | ||
| Q4 24 | $139.6M | $742.5M | ||
| Q3 24 | $85.2M | $703.6M | ||
| Q2 24 | $107.2M | $658.2M | ||
| Q1 24 | $-130.7M | $664.6M |
| Q4 25 | $123.8M | — | ||
| Q3 25 | $89.8M | — | ||
| Q2 25 | $78.0M | — | ||
| Q1 25 | $-108.7M | — | ||
| Q4 24 | $137.0M | — | ||
| Q3 24 | $82.8M | — | ||
| Q2 24 | $104.7M | — | ||
| Q1 24 | $-131.9M | — |
| Q4 25 | 28.0% | — | ||
| Q3 25 | 20.3% | — | ||
| Q2 25 | 18.9% | — | ||
| Q1 25 | -26.9% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 27.5% | — | ||
| Q1 24 | -36.3% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 4.12× | 3.86× | ||
| Q3 25 | 3.08× | 2.44× | ||
| Q2 25 | 4.12× | 12.06× | ||
| Q1 25 | -4.35× | 2.50× | ||
| Q4 24 | 4.11× | 3.57× | ||
| Q3 24 | 3.14× | 1.29× | ||
| Q2 24 | 2.86× | 6.45× | ||
| Q1 24 | -7.26× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HURN
| Consulting And Managed Services Capability | $172.9M | 39% |
| Education | $118.7M | 27% |
| Commercial | $91.9M | 21% |
| Digital Capability | $54.6M | 12% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
